EUVIMEDEUVIMED entdecken
Crossref

Fungal Uveitis – Current Diagnosis and Treatment

Agnieszka Kubicka-Trząska

Ophthalmology · 2023

DOI: 10.5114/oku/177958 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ophthalmology, 2023. Verfasst von Agnieszka Kubicka-Trząska.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ocular fungal infections annually affect more than one million individuals worldwide. They may occur as endogenous or exogenous fungal uveitis/ endophthalmitis. The latter appear after intraocular procedures, perforating ocular trauma or secondary to fungal keratitis. Although culturing is still the standard in the diagnosis of fungal endopthalmitis, more sensitive and specific and faster diagnostics tests include molecular tests; polymerase chain reaction and next generation sequencing. Also highly sensitive is the serum assessment of galactomannan and beta-D-glucan – two markers of fungal cell wall components. Treatment of fungal uveitis is difficult, mainly due to the limited permeability of antifungal drugs into intraocular fluids. In the treatment of fungal uveitis, systemic antifungal drugs are used, which in the case of vitreous involvement are combined with amphotericin B or voriconazole intravitreal injections. In cases with severe endophthalmitis and intravitreal abscess the vitrectomy is a treatment of choice.

Zitieren

APA

Kubicka-Trząska, A. (2023). Fungal Uveitis – Current Diagnosis and Treatment. Ophthalmology. https://doi.org/10.5114/oku/177958

Vancouver

Kubicka-Trząska A. Fungal Uveitis – Current Diagnosis and Treatment. Ophthalmology. 2023. doi:10.5114/oku/177958

BibTeX
@article{KubickaTrzska2023,
  author = {Kubicka-Trząska, Agnieszka},
  title = {Fungal Uveitis – Current Diagnosis and Treatment},
  journal = {Ophthalmology},
  year = {2023},
  doi = {10.5114/oku/177958}
}
Kostenlos starten →